共 10 条
- [8] Autosomal dominant optic atrophy: A novel treatment for OPA1 splice defects using U1 snRNA adaption MOLECULAR THERAPY-NUCLEIC ACIDS, 2021, 26 : 1186 - 1197
- [10] STK-002, an Antisense Oligonucleotide (ASO) for the Treatment of Autosomal Dominant Optic Atrophy (ADOA), is Taken Up by Retinal Ganglion Cells (RGC) and Upregulates OPA-1 Protein Expression After Intravitreal Administration to Non-human Primates (NHPs) INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)